Financial Results Overview

Standalone Financial Performance (₹ in millions)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹2,329.32 (vs. ₹2,113.14 in Q2 FY26)
  • Other Income (net): ₹40.22 (vs. ₹70.91 in Q2 FY26)
  • Total income: ₹2,369.54 (vs. ₹2,184.05 in Q2 FY26)
  • Total expenses: ₹1,630.40 (vs. ₹1,324.76 in Q2 FY26)
  • Profit before tax: ₹739.14 (vs. ₹859.29 in Q2 FY26)
  • Total tax expense: ₹185.63 (vs. ₹212.94 in Q2 FY26)
  • Profit for the period: ₹553.51 (vs. ₹646.35 in Q2 FY26)
  • Total comprehensive income: ₹554.12 (vs. ₹646.39 in Q2 FY26)
  • Basic EPS: ₹5.21 (vs. ₹6.08 in Q2 FY26)

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹4,400.36 (vs. ₹4,312.20 in H1 FY26)
  • Other Income (net): ₹254.07 (vs. ₹200.15 in H1 FY26)
  • Total income: ₹4,654.43 (vs. ₹4,512.35 in H1 FY26)
  • Total expenses: ₹2,940.06 (vs. ₹2,628.91 in H1 FY26)
  • Profit before tax: ₹1,714.37 (vs. ₹1,883.44 in H1 FY26)
  • Total tax expense: ₹427.95 (vs. ₹471.35 in H1 FY26)
  • Profit for the period: ₹1,286.42 (vs. ₹1,412.09 in H1 FY26)
  • Total comprehensive income: ₹1,287.63 (vs. ₹1,412.16 in H1 FY26)
  • Basic EPS: ₹12.10 (vs. ₹13.29 in H1 FY26)

Consolidated Financial Performance (₹ in millions)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹2,993.90
  • Other Income (net): ₹56.64
  • Total income: ₹3,050.54
  • Total expenses: ₹2,306.38
  • Profit before tax: ₹744.16
  • Total tax expense: ₹186.91
  • Profit for the period: ₹557.25
  • Total comprehensive income: ₹557.85
  • Basic EPS: ₹5.24

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹5,678.22
  • Other Income (net): ₹278.82
  • Total income: ₹5,957.04
  • Total expenses: ₹4,237.37
  • Profit before tax: ₹1,719.67
  • Total tax expense: ₹428.92
  • Profit for the period: ₹1,290.75
  • Total comprehensive income: ₹1,291.96
  • Basic EPS: ₹12.14

Key Operational Highlights

Employee Stock Options

During the half year ended September 30, 2026, 6,822 equity shares of ₹1 each fully paid-up were allotted upon exercise of vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021).

Strategic Collaboration

Clean-Fino Chem Limited (Subsidiary) entered into an agreement on July 16, 2026, for a long-term strategic collaboration with Geneus Chem AG, a Swiss company. The agreement covers:

  • Manufacturing and supply of advanced grades of HALS Products on a worldwide exclusive basis
  • Minimum offtake commitments and pricing mechanism
  • Geneus Chem AG will issue warrants to the Subsidiary exercisable within four years from date of issue
  • Upon exercise, the Subsidiary will acquire 25% of Geneus Chem AG's share capital on a fully diluted basis at nominal price
  • Subsequent to the half year, the Subsidiary completed product trials for these advanced HALS Products

GST Proceedings

The Maharashtra GST Department conducted search and inspection proceedings under Section 67 of the Maharashtra GST Act, 2017 at the registered office and manufacturing units of the Company and its wholly owned subsidiary, concluding on September 29, 2026.

Standalone Impact:

  • GST liability of ₹73.72 million under reverse charge mechanism (eligible for input tax credit)
  • Interest liability and non-creditable tax liabilities aggregating ₹15.87 million
  • Company deposited RCM liability and related interest in GST electronic cash ledger
  • Provision of ₹15.87 million recognized for interest and non-creditable tax liabilities

Consolidated Impact:

  • GST liability of ₹99.85 million under reverse charge mechanism (eligible for input tax credit)
  • Interest liability and non-creditable tax liabilities aggregating ₹20.20 million
  • Company deposited RCM liability and related interest in GST electronic cash ledger
  • Provision of ₹20.20 million recognized for interest and non-creditable tax liabilities

Discussions with GST authorities regarding final liability determination are ongoing. Amounts have not been finally concluded/appropriated by the Department.

International Expansion

Clean Science and Technology Limited, through its wholly owned subsidiary Clean Fino-Chem Limited, incorporated Clean Science International B.V. in the Netherlands to strengthen international presence and support business activities in Europe.

Financial Position

Standalone Balance Sheet (as of September 30, 2026, ₹ in millions)

  • Total assets: ₹19,189.55 (vs. ₹17,839.58 as of March 31, 2026)
  • Total equity: ₹17,332.64 (vs. ₹16,456.44 as of March 31, 2026)
  • Total liabilities: ₹1,856.91 (vs. ₹1,383.14 as of March 31, 2026)
  • Investments: ₹11,412.79 (₹9,516.93 non-current + ₹1,895.86 current)
  • Inventories: ₹1,416.62 (vs. ₹1,019.44 as of March 31, 2026)

Consolidated Balance Sheet (as of September 30, 2026, ₹ in millions)

  • Total assets: ₹19,203.82 (vs. ₹17,829.07 as of March 31, 2026)
  • Total equity: ₹16,718.25 (vs. ₹15,837.71 as of March 31, 2026)
  • Total liabilities: ₹2,485.57 (vs. ₹1,991.36 as of March 31, 2026)

Cash Flow Statements

Standalone Cash Flows (H1 FY27, ₹ in millions):

  • Net cash from operating activities: ₹812.60
  • Net cash used in investing activities: ₹(512.01)
  • Net cash used in financing activities: ₹(436.80)
  • Net decrease in cash: ₹(136.21)

Consolidated Cash Flows (H1 FY27, ₹ in millions):

  • Net cash from operating activities: ₹718.62
  • Net cash used in investing activities: ₹(396.30)
  • Net cash used in financing activities: ₹(441.58)
  • Net decrease in cash: ₹(119.26)

Availability of Results

The standalone and consolidated results are available on the Company's website (www.cleanscience.co.in) and on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Limited (www.nseindia.com).

#Tags: #CleanScience #Q2Results #FY27 #GSTProceedings #GeneusChemCollaboration #SEBIDisclosure #FinancialResults #RegulatoryCompliance #Neutral